- Presentations
- 2
- Markets
- 1
Kevzara is a brand of Sarilumab marketed by Sanofi-Aventis, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Sarilumab
- Brand owner
- Sanofi-Aventis
- Registered in
- United States
- Strengths and forms
- 150 mg/1.14 mL injection, 200 mg/1.14 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Kevzara 150 mg/1.14 mL injectionSubcutaneous Cold chain | Sanofi-Aventis | US FDA | Available on request |
| Kevzara 200 mg/1.14 mL injectionSubcutaneous Cold chain | Sanofi-Aventis | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Kevzara
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.